Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
About this ETF
The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors. These are recognized as some of the most rapidly evolving and research-intensive fields within healthcare. The ETF's objective is to emulate the returns of the BITA Global Pharma and Biotech Select Index, which tracks businesses operating in developed markets that generate a significant portion of their earnings from the invention, progression, and sale of treatments for human health.
Price
Top 10 holdings
| ELI LILLY & CO LLY.TO | 15.96% |
| JOHNSON & JOHNSON JNJ | 9.68% |
| ABBVIE INC ABBV | 6.86% |
| MERCK & CO. INC. MRK | 4.80% |
| ROCHE HOLDING AG | 4.47% |
| NOVARTIS AG-REG NOVN.SW | 4.37% |
| AMGEN INC AMGN | 4.34% |
| ASTRAZENECA PLC AZN.L | 4.06% |
| GILEAD SCIENCES INC GILD | 3.87% |
| NOVO NORDISK A/S-B | 3.61% |
Sector mix
No sector breakdown available for this fund.
Price chart
Returns
| 1 month | +5.68% |
| 3 months | +5.68% |
| 6 months | +4.77% |
| Year to date | +6.93% |
| 1 year | — |
| 3 years (ann.) | — |
| 5 years (ann.) | — |
| 10 years (ann.) | — |
Risk profile
| Volatility (1y, ann.) | — |
| Sharpe (1y) | — |
| Sharpe (3y) | — |
| Sortino (1y) | — |
| Max drawdown (1y) | — |
| Max drawdown (5y) | — |
| Max drawdown (full) | -11.09% |
| Beta vs S&P 500 (1y) | 0.44 |
| Correlation vs S&P 500 (1y) | 0.32 |
Technical outlook not available yet — this fund does not have enough price history for the statistical models.
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Geographic exposure
Cost vs. peers
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
No distributions on record — accumulating share classes reinvest income instead of paying it out.
ESG profile
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Schwab U.S. Dividend Equity ETF SCHD | 0.06% | 98.55B | 11.3% |
| Vanguard High Dividend Yield ETF VYM | 0.04% | 96.10B | 7.2% |
| Vanguard Dividend Appreciation ETF VIG | 0.04% | 127.80B | 7.1% |
| Vanguard Value ETF VTV | 0.03% | 245.00B | 6.8% |
| iShares Core MSCI EAFE ETF IEFA | 0.07% | 187.22B | 3.7% |
